Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Author is Edwards, Kathryn  [Clear All Filters]
Journal Article
S. E. Frey, Wald, A., Edupuganti, S., Jackson, L. A., Stapleton, J. T., Sahly, H. El, El-Kamary, S. S., Edwards, K., Keyserling, H., Winokur, P., Keitel, W., Hill, H., Goll, J. B., Anderson, E. L., Graham, I. L., Johnston, C., Mulligan, M., Rouphael, N., Atmar, R., Patel, S., Chen, W., Kotloff, K., C Creech, B., Chaplin, P., and Belshe, R. B., Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects., Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
E. J. Anderson, Lopman, B., Yi, J., Libster, R., C Creech, B., El-Khorazaty, J., Baqar, S., Yildirim, I., Kao, C., Rouphael, N., Shane, A. L., and Edwards, K., Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine., J Pediatric Infect Dis Soc, vol. 9, no. 4, pp. 479-482, 2020.
D. F. Hoft, Lottenbach, K., Goll, J. B., Hill, H., Winokur, P. L., Patel, S. M., Brady, R. C., Chen, W. H., Edwards, K., C Creech, B., Frey, S. E., Blevins, T. P., Salomon, R., and Belshe, R. B., Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination., J Infect Dis, vol. 214, no. 7, pp. 1020-9, 2016.
L. A. Jackson, Sahly, H. M. El, George, S., Winokur, P., Edwards, K., Brady, R. C., Rouphael, N., Keitel, W. A., Mulligan, M. J., Burton, R. L., Nakamura, A., Ferreria, J., and Nahm, M. H., Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine., Vaccine, vol. 36, no. 5, pp. 606-614, 2018.
G. Miller, Schaefer, H., Yoder, S., Miller, R., Winokur, P., Kotloff, K., Klassen, D., Wierzbicki, M., Amegashie, C., and Edwards, K., A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation., Transpl Infect Dis, vol. 20, no. 3, p. e12874, 2018.